IP Library Granted Patent US 11,293,917
Granted Patent B2
US 11,293,917 · App. 16/894,369 · Granted Apr 5, 2022

Systems for analyzing target biological molecules via sample imaging and delivery of probes to substrate wells

Inventor: Mark S. Chee (San Diego, CA)
Assignee: Prognosys Biosciences, Inc.
G01N33/543B01L3/502715C12Q1/6804C12Q1/6809C12Q1/6834C12Q1/6837C12Q1/6841C12Q1/6869C12Q1/6874C40B30/04C40B60/04G01N33/5308G01N33/6845G01N2458/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,293,917
App. No.
16/894,369
Granted
Apr 5, 2022
Kind
B2
Abstract

The present invention provides assays and assay systems for use in spatially encoded biological assays. The invention provides an assay system comprising an assay capable of high levels of multiplexing where reagents are provided to a biological sample in defined spatial patterns; instrumentation capable of controlled delivery of reagents according to the spatial patterns; and a decoding scheme providing a readout that is digital in nature.

Claims (28)

1. A system for analyzing a target biological molecule of a tissue sample that has been deposited on a solid support and that comprises a plurality of probes, each probe of the plurality of probes comprising a capture agent conjugated to an oligonucleotide comprising a sequence, the system comprising:

an imager comprising at least one of a two-dimensional CCD array and a two-dimensional CMOS array, wherein the imager is configured to obtain an image of the tissue sample;

a processing circuit arrangement connected to the imager and comprising software;

an interface connected to the processing circuit arrangement and comprising a visual display; and

a reagent delivery system comprising at least one reagent channel that is positionable relative to a location of the tissue sample,

wherein the software comprises instructions configured to cause the processing circuit arrangement to:

display an image of the tissue sample obtained by the imager on the visual display and obtain information about a region of interest in the tissue sample based on the image of the tissue sample, wherein the region of interest is less than the entire tissue sample; and

control the reagent delivery system to remove a portion of the tissue sample from the region of interest and deliver the removed portion of the tissue sample through the at least one reagent channel to a location external to the tissue sample,

wherein the removed portion of the tissue sample comprises an oligonucleotide of one of the plurality of probes in the tissue sample; and

wherein the location external to the tissue sample is a well in a substrate, and wherein the well is associated with the region of interest.

2. The system of claim 1 , wherein the software comprises instructions configured to cause the processing circuit arrangement to obtain information about multiple regions of interest in the tissue sample based on the image of the tissue sample.

3. The system of claim 2 , wherein:

the multiple regions of interest comprise a first region of interest and a second region of interest;

the portion of the tissue sample is a first portion of the tissue sample, the location external to the tissue sample is a first location external to the tissue sample, the target biological molecule is a first target biological molecule, the oligonucleotide is a first oligonucleotide, and the well is a first well;

the software comprises further instructions configured to cause the processing circuit arrangement to control the reagent delivery system to remove a second portion of the tissue sample from the second region of interest and deliver the removed second portion of the tissue sample to a second location external to the tissue sample,

wherein the second removed portion of the tissue sample comprises a second oligonucleotide of another one of the plurality of probes in the tissue sample; and

wherein the second location external to the tissue sample is a second well in the substrate, and wherein the second well is associated with the second region of interest in the tissue sample.

4. The system of claim 3 , wherein the software comprises instructions configured to cause the processing circuit arrangement to control the reagent delivery system to deliver the removed first and second portions of the tissue sample to the respective first and second external locations sequentially.

5. The system of claim 3 , wherein the software comprises instructions configured to cause the processing circuit arrangement to control the reagent delivery system to deliver an elution composition sequentially to the first and second regions of interest to remove the first and second portions of the tissue sample.

6. The system of claim 1 , wherein the software comprises instructions configured to cause the processing circuit arrangement to obtain the information about the region of interest in the tissue sample from the image of the tissue sample.

7. The system of claim 6 , wherein the software comprises instructions configured to cause the processing circuit arrangement to obtain the information about the region of interest in the tissue sample based on differentiated staining of the tissue sample identified in the image of the tissue sample.

8. The system of claim 1 , wherein the software comprises instructions configured to cause the processing circuit arrangement to receive the information about the region of interest in the tissue sample from a user of the system.

9. The system of claim 1 , further comprising a gasket positionable atop the tissue sample.

10. The system of claim 9 , wherein the software comprises instructions configured to cause the processing circuit arrangement to obtain the information about the region of interest in the tissue sample based on differentiated immunohistochemistry of the tissue sample identified in the image of the tissue sample.

11. The system of claim 1 , wherein the imager is configured to obtain the image of the tissue sample when the tissue sample is stained.

12. The system of claim 1 , wherein the imager is configured to obtain the image of the tissue sample as a fluorescence image.

13. The system of claim 1 , wherein the at least one reagent channel is positionable atop the tissue sample to allow delivery of reagents to discrete portions of the tissue sample.

14. The system of claim 1 , wherein the reagent delivery system comprises a pump configured to drive fluid flow to deliver the removed portion of the tissue sample to the external location.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2020
From: CHEE, MARK S.
To: PROGNOSYS BIOSCIENCES, INC.
Reel/Frame 052947/0859 →
Continuity (9)
Continuation 16435176 · Jun 7, 2019
Continuation 16430015 · Jun 3, 2019
Continuation 16414213 · May 16, 2019
Continuation 16402098 · May 2, 2019
Continuation 16276235 · Feb 14, 2019
Continuation 15187661 · Jun 20, 2016
Continuation 13080616 · Apr 5, 2011
Provisional Application 61321124 · Apr 5, 2010
Related Publication 20200299757A1 · Sep 24, 2020
Cited By (41)
US 12,195,790 US 12,203,134 US 12,209,280 US 12,223,751 US 12,228,544 US 12,241,060 US 12,241,890 US 12,249,085 US 12,265,079 US 12,270,077 US 12,275,988 US 12,281,357 US 12,286,673 US 12,287,264 US 12,297,486 US 12,344,892 US 12,365,935 US 12,365,942 US 12,371,688 US 12,378,607 US 12,385,083 US 12,399,123 US 12,404,544 US 12,405,264 US 12,416,603 US 12,435,363 US 12,442,045 US 12,460,319 US 12,497,654 US 12,508,590 US 12,529,094 US 12,545,949 US 12,553,805 US 12,553,898 US 12,566,113 US 12,566,114 US 12,571,029 US 12,624,475 US 12,637,706 US 12,668,835 US 12,692,492